The Cigna Group, together with its subsidiaries, operates as a global health company.
Segments
The company operates in two segments: Evernorth Health Services and Cigna Healthcare. The Evernorth Health Services segment, through its Pharmacy Benefit…
Analysis
Bargain bin
The Cigna Group is priced cheaply, and that invites the natural question of why, since the underlying business scores below average. Worth noting: the cash the business generates has lagged behind what the income statement shows.
On valuation, the picture is attractive. The owner-earnings multiple stands at 11.3×; owner earnings: the cash an owner could take out each year. The implied growth embedded in that price is around -1% a year, against analyst forecasts of 10%. The price, in other words, assumes less than the experts do.
Growth is tepid; the safety picture is sturdy. The company scores 18/20 on our value-creation score: strong value creator.
Flags to be aware of: Reported profits have run ahead of actual cash for several periods. As always: this describes the company's numbers; it is not a recommendation.
360° rank · history
1007550250
Jan 202390
79
2023202420252026
All-time high
98
Jan 2026
All-time low
78
Feb 2026
Average rank
93
across all years
Detailed & Historical Ranks
Deep dive into 15 detailed ranks and 3 years of history.
Current202520242023
Price/Sales
100
83
82
95
Price/Earnings
13
90
80
97
Price/Book
67
55
59
72
Dividend Yield
100
90
89
87
Value (overall)
98
98
95
98
Cells are coloured by rank band (red weak → green strong). Sentiment & 360° history begins 2023.